SMC announces first long-acting injectable HIV treatment
October 12, 2021Manufacturing and Production
The Scottish Medicines Consortium (SMC) has approved the first long-acting injectable regimen for people living with HIV in Scotland, manufactured …
AstraZeneca’s antibody cocktail cuts risk of severe COVID in half, study finds
October 12, 2021Manufacturing and Production
AstraZeneca’s antibody cocktail against COVID-19, which has proven to work as a preventative shot in the non-infected, has been successful …
UK government COVID response “one of UK’s worst ever public health failures”, inquiry finds
October 12, 2021Manufacturing and Production, Medical Communications
A 150-page report published on Tuesday by the House of Commons, Science and Technology Committee, and Health and Social Care …
SparkRx depression therapeutic shown to cut depression symptoms in adolescents
October 11, 2021Sales and Marketing FDA, Limbix, SparkRx
A new digital therapeutic available for use without prescription under the FDA’s emergency guidance for digital health devices has shown …
NICE approves treatment for rheumatoid arthritis
October 11, 2021Sales and Marketing
NICE has issued a positive final appraisal document recommending upadacitinib, a once-daily oral therapy, for people with previously treated moderate …
Two Indian drugmakers to discontinue MSD’s molnupiravir
October 8, 2021Medical Communications
AuroBindo Pharma Ltd and MSD Laboratories plan to end their respective trials of MSD’s experimental antiviral drug molnupiravir in moderate …
Samsung Biologics partners with Enzolytics Inc for antibody therapies
October 8, 2021Medical Communications
Leading manufacturing organisation Samsung Biologics, alongside drug development company Enzolytics, have announced the signing of a strategic CDMO partnership agreement. …
Talem Therapeutics and Pierre Fabre to form antibody research collaboration
October 8, 2021Medical Communications
Talem Therapeutics, subsidiary of Immunoprecise Antibodies Ltd (IPA), and the Pierre Fabre pharmaceutical group have announced a multi-target research collaboration, …
Finland joins Sweden and Denmark to limit use of Moderna vaccine
October 8, 2021Medical Communications
On Thursday, Finland became the latest country to suspend the use of Moderna’s COVID vaccine on younger males, amid reports …
UN Secretary General makes $8 billion plea to vaccinate 40% of world in 2021
October 8, 2021Medical Communications
UN Secretary-General, Antonio Guterres, appealed on Thursday for $8 billion to help equitably vaccinate 40% of people in all countries …
Women and children most impacted by mental health during pandemic
October 7, 2021Business Services
The Headway 2023 Mental Health Index has revealed that the pandemic has taken a significant toll on the mental health …
Incyte trial reveals encouraging results for patients with vitiligo
October 7, 2021Business Services
Incyte has announced full results from its Phase III TRuE-V Program, evaluating Ruxolitinib Cream in patients with vitiligo. Treatment with …
Nobel Prize awarded to molecule construction champions
October 7, 2021Business Services
Benjamin List and David MacMillan have been awarded the Nobel prize in chemistry, for their construction of a tool used …
Pfizer enlists entire town in Brazil for COVID study
October 7, 2021Research and Development
An entire town in Brazil has been enrolled by Pfizer to study the transmission of the coronavirus within a vaccinated …
WHO rolls out GSK’s malaria vaccine in Africa
October 7, 2021Medical Communications, Research and Development
The WHO has given the go-ahead for the mass roll out of a malaria vaccine for children, in a historic …
Janssen’s bowel disease drug shown to be safe for use in older patients
October 6, 2021Research and Development
The Janssen Pharmaceutical Companies of J&J have announced that STELARA® (ustekinumab) has a high safety profile in older patients across …
UroGen Pharma shows positive results for bladder cancer patients
October 6, 2021Research and Development
UroGen Pharma Ltd has published results from the Phase IIb OPTIMA II trial, a single-arm trial studying UGN-102 (mitomycin) as …
Third dose of COVID-19 vaccine approved for immunocompromised over 12
October 6, 2021Research and Development
The EMA have authorised the third dose of the Moderna COVID-19 vaccine (Spikevax), to be administered on immunocompromised individuals aged …
Merck secures Singapore deal for COVID antiviral pill
October 6, 2021Medical Communications, Research and Development
Merck announced on Wednesday a supply and purchase agreement that will provide Singapore with access to its experimental oral COVID-19 …
Bayer wins first court case in Roundup child cancer battle
October 6, 2021Medical Communications, Research and Development
Bayer AG has won its first court case over claims its Roundup weed killer causes cancer after a California jury …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
